Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $345.96 | 25 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $345.96 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.37 | 1 | Novo Nordisk Inc ($17.37) |
| 2023 | $148.17 | 16 | Novo Nordisk Inc ($148.17) |
| 2022 | $180.42 | 8 | Novo Nordisk Inc ($180.42) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/14/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Diabetes | ||||||
| 12/05/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $8.02 | General |
| Category: Diabetes | ||||||
| 10/23/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Diabetes | ||||||
| 10/13/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $7.01 | General |
| Category: Diabetes | ||||||
| 09/26/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $5.50 | General |
| Category: Diabetes | ||||||
| 09/08/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $4.99 | General |
| Category: Diabetes | ||||||
| 06/29/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Diabetes | ||||||
| 06/16/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $7.08 | General |
| Category: Diabetes | ||||||
| 06/06/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.41 | General |
| 06/02/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $4.88 | General |
| Category: Diabetes | ||||||
| 05/12/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $3.67 | General |
| Category: Diabetes | ||||||
| 04/14/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $6.59 | General |
| Category: Diabetes | ||||||
| 04/07/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Diabetes | ||||||
| 03/04/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.50 | General |
| Category: Diabetes | ||||||
| 02/17/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.59 | General |
| Category: Diabetes | ||||||
| 01/27/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.10 | General |
| Category: Diabetes | ||||||
| 01/10/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus, Tresiba | Food and Beverage | In-kind items and services | $9.86 | General |
| Category: Diabetes | ||||||
| 12/08/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus, Tresiba | Food and Beverage | In-kind items and services | $9.22 | General |
| Category: Diabetes | ||||||
| 11/16/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus, Tresiba | Food and Beverage | In-kind items and services | $9.54 | General |
| Category: Diabetes | ||||||
| 11/02/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $121.16 | General |
| Category: Diabetes | ||||||
| 10/20/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus, Tresiba | Food and Beverage | In-kind items and services | $6.47 | General |
| Category: Diabetes | ||||||
| 09/27/2022 | Novo Nordisk Inc | Tresiba (Drug), Rybelsus, Ozempic | Food and Beverage | In-kind items and services | $6.43 | General |
| Category: Diabetes | ||||||
| 08/19/2022 | Novo Nordisk Inc | Tresiba (Drug), Rybelsus, Ozempic | Food and Beverage | In-kind items and services | $7.68 | General |
| Category: Diabetes | ||||||
| 08/05/2022 | Novo Nordisk Inc | Tresiba (Drug), Rybelsus, Ozempic | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: Diabetes | ||||||
| 06/28/2022 | Novo Nordisk Inc | Rybelsus (Drug), Tresiba, Ozempic | Food and Beverage | In-kind items and services | $7.86 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 186 | 207 | $31,066 | $12,104 |
| 2022 | 2 | 60 | 62 | $9,036 | $3,754 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 84 | 100 | $19,000 | $7,108 | 37.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 48 | $6,432 | $2,007 | 31.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 18 | 18 | $3,240 | $1,770 | 54.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 12 | 12 | $1,728 | $833.91 | 48.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $396.00 | $322.96 | 81.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 17 | 18 | $270.00 | $61.38 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 47 | 49 | $6,566 | $2,671 | 40.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 13 | $2,470 | $1,083 | 43.9% |
About Cameron Munafo, CNP
Cameron Munafo, CNP is a Family healthcare provider based in Fairfield, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/22/2021. The National Provider Identifier (NPI) number assigned to this provider is 1275119174.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cameron Munafo, CNP has received a total of $345.96 in payments from pharmaceutical and medical device companies, with $17.37 received in 2024. These payments were reported across 25 transactions from 1 company. The most common payment nature is "Food and Beverage" ($345.96).
As a Medicare-enrolled provider, Munafo has provided services to 246 Medicare beneficiaries, totaling 269 services with total Medicare billing of $15,858. Data is available for 2 years (2022–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Fairfield, OH
- Active Since 03/22/2021
- Last Updated 06/07/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1275119174
Products in Payments
- Rybelsus (Drug) $207.55
- Ozempic (Drug) $92.83
- Tresiba (Drug) $26.17
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Fairfield
Laurie Bresee
Family — Payments: $11,797
Ayisha Ilias, Fnp-C, FNP-C
Family — Payments: $6,729
Mr. Manuel Marquez, Fnp, FNP
Family — Payments: $6,505
Todd Clark, Aprn, APRN
Family — Payments: $4,297
Mr. Stephen Rogers, Fnp-C, FNP-C
Family — Payments: $4,208
Ms. Jillian Ross, A.p.r.n, A.P.R.N
Family — Payments: $3,749